AKT1 and cancer: We also show that activated OPTN has a potential activating effect on the activity of EMT (25%) and Apoptosis (16%) pathways, as well as a potential inhibitory effect on the activity of the Cell cycle (19%), DNA damage (16%) hormone AR (16%) and PI3K/AKT (12%) in pan-cancer (Figure 3a).